title: Exhaled nitric oxide at school age in prematurely born infants with neonatal chronic lung disease.
abstract: Prematurely born infants with neonatal chronic lung disease (CLD) have increased respiratory morbidity and bronchial obstruction at school age. To evaluate the possible inflammatory basis of lung function abnormalities, we studied 40 children, 7.5-9.6 years of age, born very prematurely (birth weights, 600-1,575 g) and 14 nonatopic term-born controls, using flow-volume spirometry and exhaled nitric oxide (eNO) measurements. In children born prematurely, eNO was significantly higher in atopics than in nonatopics (respective means, 14.8 vs. 6.3 ppb, P = 0.02). Nonatopic prematurely born infants did not differ significantly from controls (means, 6.3 vs. 6.4 ppb, P = ns). Of the 27 nonatopic children not on regular glucocorticoid inhalations, 9 had a history of CLD. Spirometry indicated bronchial obstruction and values that were significantly lower in prematurely born infants with or without CLD than in controls, and they were lower in the CLD than the non-CLD group. However, no significant differences were observed in eNO levels between CLD, non-CLD, and control groups (means, 6.8, 5.9, and 6.4 ppb, P = ns). In nonatopic schoolchildren born very prematurely and with a history of CLD, we found no evidence of airway inflammation associated with increased eNO concentrations. Neither were eNO levels associated with severity of chronic lung disease, as determined by conventional lung function tests. eNO levels were higher in atopic children born prematurely than in controls.
authors.affiliation: Department of Pediatrics, Jorvi Hospital, Espoo, Finland. suvi.mieskonen@hus.fi
authors.forename: Suvi T
authors.initials: ST
authors.lastname: Mieskonen
authors.forename: L Pekka
authors.initials: LP
authors.lastname: Malmberg
authors.forename: M Anneli
authors.initials: MA
authors.lastname: Kari
authors.forename: Anna S
authors.initials: AS
authors.lastname: Pelkonen
authors.forename: Markku T
authors.initials: MT
authors.lastname: Turpeinen
authors.forename: N Mikko K
authors.initials: NM
authors.lastname: Hallman
authors.forename: Anssi R A
authors.initials: AR
authors.lastname: Sovijärvi
mesh_terms: D002648:Child; D002908:Chronic Disease; D005260:Female; D005387:Finland; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000502:physiology*; D008171:Lung Diseases / Q000503:physiopathology*; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D011653:Pulmonary Diffusing Capacity / Q000502:physiology*; D012129:Respiratory Function Tests
chemical_list: D009569:Nitric Oxide